This article explains how the venture business acts as a catalyst in the evolution of DOS contract research and development companies with special technology in a DOS field. The venture business prepares the DDS contract company for their research and development collaborations with pharmaceutical companies. The article is based on a large DOS database created in 1980, and maintained daily to date, involving DDS companies, venture capital, technologies and collaborations in drug delivery R&D.
Venture firms generally seek to sell most of their shares within about five to seven years of their initial investment : typically, they will sell after the company floats its shares on a public stock market.
This article traces capital formation for the DDS entrepreneur leading to a contract development business, and an internal DDS product business, and how pharmaceutical companies access the DDS technology through drug delivery colIaborations4).
How DDS companies were formed and kept in operation
The most famous DDS company is ALZA, founded by Alejandro Zaffaroni in 1968, based on an idea he had as a student at the University of 
